VP Business Development & Regulatory Affairs
Pharmaceuticals · Europe · Germany · Berlin
Total compensation band $150K+. The figure is the member's band, not an offer.
Pharmaceutical executive with track record of building businesses and functions from zero to scale. Progressed from regulatory specialist through CRO founder to VP-level leadership at specialty pharma company. Created entirely new CDMO business line, built 50+ country regulatory engine enabling 9-digit portfolio value, and drove 20% annual revenue growth. Combines deep scientific expertise with commercial leadership and proven ability to execute across full pharma value chain.
Achievements
- Created entirely new CDMO business line and closed Tier-1 pharma contracts within 24 months
- Built 50+ country regulatory engine managing 100+ dossiers enabling 9-digit portfolio value
- Founded profitable CRO achieving 6-digit revenue in year one as sole director
- EU marketing authorization holder for pioneering cardiovascular FDC sold in 41 countries with 228M+ units
- Resolved critical compliance risks that threatened 9-digit Tier-1 pharma M&A transaction
Skills
- Commercial Strategy
- Business Development
- P&L Ownership
- Cross-functional Leadership
- M&A Support
- Global Leadership
- Pharmaceutical
- Biotech
- Quality Control
- Global Regulatory Affairs (50+ Countries)
- Pharmacovigilance Systems
- CDMO Business Development
Looking for
- Chief Commercial Officer
- Chief Operating Officer
- VP Business Development
Experience
- Independent Management Consultant / Owner — Dr. Molchanov Management Consultancy 08/2025 - Present
C-level strategic advisory to pharma/MedTech companies on business development, regulatory, quality, and launch strategy. Due diligence and exit preparation support for VC/PE investors in life sciences transactions.
- Vice President Business Development & Regulatory Affairs — AMW GmbH 04/2021 - 05/2025
Built CDMO business line from concept, closed Tier-1 pharma contracts, and scaled regulatory affairs to 50+ countries managing 100+ dossiers. Enabled 9-digit portfolio value and 20% annual revenue growth.
- Managing Director / Owner — Fontane Pharma GmbH 09/2017 - 03/2021
Founded and operated CRO achieving 6-digit revenue in year one. EU marketing authorization holder for cardiovascular FDC now sold in 41 countries with 228M+ units globally.
- Managing Consultant / Department Head Pharmacovigilance — Xendo GmbH / ProPharma Group 11/2015 - 07/2017
Built PV department from scratch with 700K Euro P&L responsibility, grew team to double-digit headcount while maintaining service quality and securing new pharma partnerships.
- Manager Regulatory Affairs & Pharmacovigilance — Brinker Pharma / Xendo GmbH 2012 - 2015
Contributed to first radioligand-based therapy marketing authorizations in Europe. Led regulatory submissions for radiopharmaceutical products with prominent industry partners.
- Scientific Fellow / PhD Researcher — Free University Berlin 2009 - 2012
Led student training programs in instrumental analytics and conducted novel research on fluorinated platinum complexes for cancer therapy targeting.
Languages
- German (C2)
- Russian (C2)
- English (C1)
- Spanish (B2)
Anonymous until this leader says yes. No name, no photo, no contact details. An introduction is sent only after they accept.
Similar profiles
- CEO and Chief Digital/E-commerce Officer Pharmaceuticals · Pharmaceuticals · CIS
- Director of Economics and Investments FMCG · FMCG · Russia
- Head of HR FinTech · FinTech · Europe
- Chief Commercial Officer / VP of Business Development FMCG · FMCG · Russia
- CEO IT Infrastructure · IT Infrastructure · CIS
- Transformation & Business Development Director | Lubricants, Specialty Chemicals & Formulated Products | EMEA Energy & Oil · Energy & Oil · EMEA
All published profiles · Browse the featured cards · For companies